Pre-Visit Prioritization for Complex Patients With Diabetes (PVP)
Diabetes Mellitus, Type 2

About this trial
This is an interventional health services research trial for Diabetes Mellitus, Type 2 focused on measuring Electronic Medical Records, Primary Health Care, Diabetes Mellitus, Type 2
Eligibility Criteria
Primary care physicians (PCPs) at Kaiser Permanente Northern California with potentially eligible patients (type 2 diabetes and HbA1c > 8.0%) wil be recruited and consented to participate in this study. PCPs will review lists of potentially eligible patients of theirs (defined below). Patients approved by PCP's allocated to the intervention arm will be sent a secure message on the PCPs behalf asking them to review the Pre-Visit Prioritization Questionnaire to identify top priorities for discussion at the next scheduled visit.
Patient Inclusion Criteria:
- Current adult member (> 21 years old)
- Diagnosis of type 2 diabetes with most recent HbA1c > 8.0%
- English as primary language
- Registered on kp.org.
Patient Exclusion Criteria:
- Excluded by PCP, and/or: terminal illness, in hospice care or reside in a long-term care facility, severe mental illness (e.g. schizophrenia or personality disorder), currently or recently pregnant, and/or significant dementia
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Pre-Visit Tool
Usual Care Control
Patients whose primary care physicians are allocated to the intervention arm will receive a secure electronic message shortly after scheduling an appointment with their provider asking them to complete a pre-visit prioritization survey using the kp.org patient portal
Patients whose primary care physicians are allocated to the control arm will continue with usual care